Class information for:
Level 1: HEPATOCELLULAR CARCINOMA//TRANSARTERIAL CHEMOEMBOLIZATION//MIRIPLATIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
32 4927 35.4 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
597 13382 HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 HEPATOCELLULAR CARCINOMA Author keyword 304 13% 44% 2190
2 TRANSARTERIAL CHEMOEMBOLIZATION Author keyword 130 51% 4% 183
3 MIRIPLATIN Author keyword 99 97% 1% 29
4 CHEMOEMBOLIZATION Author keyword 84 34% 4% 200
5 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION Author keyword 84 44% 3% 145
6 SORAFENIB Author keyword 68 19% 6% 316
7 ADVANCED HEPATOCELLULAR CARCINOMA Author keyword 50 76% 1% 35
8 HEPATIC ARTERIAL INFUSION CHEMOTHERAPY Author keyword 35 52% 1% 48
9 LIPIODOL Author keyword 34 35% 2% 78
10 PERCUTANEOUS ETHANOL INJECTION Author keyword 27 37% 1% 60

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 HEPATOCELLULAR CARCINOMA 304 13% 44% 2190 Search HEPATOCELLULAR+CARCINOMA Search HEPATOCELLULAR+CARCINOMA
2 TRANSARTERIAL CHEMOEMBOLIZATION 130 51% 4% 183 Search TRANSARTERIAL+CHEMOEMBOLIZATION Search TRANSARTERIAL+CHEMOEMBOLIZATION
3 MIRIPLATIN 99 97% 1% 29 Search MIRIPLATIN Search MIRIPLATIN
4 CHEMOEMBOLIZATION 84 34% 4% 200 Search CHEMOEMBOLIZATION Search CHEMOEMBOLIZATION
5 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION 84 44% 3% 145 Search TRANSCATHETER+ARTERIAL+CHEMOEMBOLIZATION Search TRANSCATHETER+ARTERIAL+CHEMOEMBOLIZATION
6 SORAFENIB 68 19% 6% 316 Search SORAFENIB Search SORAFENIB
7 ADVANCED HEPATOCELLULAR CARCINOMA 50 76% 1% 35 Search ADVANCED+HEPATOCELLULAR+CARCINOMA Search ADVANCED+HEPATOCELLULAR+CARCINOMA
8 HEPATIC ARTERIAL INFUSION CHEMOTHERAPY 35 52% 1% 48 Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY Search HEPATIC+ARTERIAL+INFUSION+CHEMOTHERAPY
9 LIPIODOL 34 35% 2% 78 Search LIPIODOL Search LIPIODOL
10 PERCUTANEOUS ETHANOL INJECTION 27 37% 1% 60 Search PERCUTANEOUS+ETHANOL+INJECTION Search PERCUTANEOUS+ETHANOL+INJECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTRAHEPATIC RECURRENCE 335 56% 8% 412
2 TRANSARTERIAL CHEMOEMBOLIZATION 249 46% 8% 409
3 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION 248 45% 9% 419
4 LIPIODOL CHEMOEMBOLIZATION 226 69% 4% 194
5 CLIP SCORE 199 77% 3% 135
6 OILY CHEMOEMBOLIZATION 184 77% 3% 127
7 PERCUTANEOUS ETHANOL INJECTION 140 32% 8% 370
8 ETHIODIZED OIL 109 92% 1% 44
9 IODIZED OIL 106 44% 4% 184
10 CHEMOEMBOLIZATION 98 25% 7% 340

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
CURRENT CONCEPTS Hepatocellular Carcinoma 2011 729 50 38%
Hepatocellular carcinoma 2003 2247 114 54%
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival 2003 1230 80 69%
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference 2001 2277 114 50%
Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis 2015 4 31 48%
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization 2011 129 90 92%
Prognosis of hepatocellular carcinoma: The BCLC staging classification 1999 1069 43 79%
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma 2010 557 12 50%
Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies 2007 306 108 82%
Management of hepatoceullular carcinoma 2005 2778 295 36%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 UNITA SEMEIOT MED 21 85% 0.2% 11
2 LIVER TUMOR PROGRAM 11 65% 0.2% 11
3 MT SINAI LIVER CANC PROGRAM 8 31% 0.4% 22
4 BARCELONA CLIN LIVER CANC BCLC GRP 7 64% 0.1% 7
5 UNITA MED 7 67% 0.1% 6
6 BCLC GRP 6 35% 0.3% 14
7 UNITA MED INTERNA GASTROENTEROL 5 60% 0.1% 6
8 BARCELONA CLIN LIVER CANC GRP 5 36% 0.2% 12
9 DIPARTIMENTO SCI CHIRURG GASTROENTEROL 5 20% 0.5% 23
10 UNITA GASTROENTEROL 5 25% 0.3% 16

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000270480 MILAN CRITERIA//UCSF CRITERIA//SALVAGE LIVER TRANSPLANTATION
2 0.0000171728 MCA RH7777//LIVER ANGIOGRAPHY//INTERVENT RADIOL RADIOL
3 0.0000158686 RADIATION INDUCED LIVER DISEASE//RADIATION INDUCED LIVER INJURY//YONSEI LIVER CANC CLIN
4 0.0000152493 DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73
5 0.0000144380 ADENOMATOUS HYPERPLASIA//MACROREGENERATIVE NODULES//LIVER CELL DYSPLASIA
6 0.0000138629 EXTREMELY ELDERLY PATIENTS//FLORIDA EPIDEM INTELLIGENCE SERV//ABT HEPATOBILIARE CHIRURG LEBER PANKREAS MULT
7 0.0000135770 RUPTURED HEPATOCELLULAR CARCINOMA//EXTRAHEPATIC METASTASIS//SKULL METASTASIS
8 0.0000131226 RADIOEMBOLIZATION//Y 90 MICROSPHERES//SELECTIVE INTERNAL RADIATION THERAPY
9 0.0000121222 RADIO FREQUENCY ABLATION//MICROWAVE ABLATION//RADIOFREQUENCY RF ABLATION
10 0.0000094905 RIGHT ATRIAL METASTASIS//TOTAL HEPATIC VASCULAR EXCLUSION//TUMOR THROMBI